Iclusig Recall Issued Due to Risk of Blood Clots, Blood Vessel Narrowing
The makers of the leukemia drug Iclusig have suspended sales in the face of alarmingly high blood clots that have led to serious injuries among patients.
November 04, 2013 By: Irvin Jackson
The makers of the leukemia drug Iclusig have suspended sales in the face of alarmingly high blood clots that have led to serious injuries among patients.
Plaintiffs filing Tepezza hearing loss lawsuits claim Horizon Therapeutics, the manufacturer, knew for years that the thyroid eye disease was linked to widespread reports of hearing problems.
The U.S. government has outlined requirements for qualifying for Camp Lejeune elective option settlement offers.
A $479 million Philips CPAP class action settlement agreement will resolve claims of economic loss filed by users of the recalled devices.